Tag: Glucagon-like peptide-1 receptor agonist

Tag Visualization: Top 50 related tags by occurrence

Recent Related Articles to Glucagon-like peptide-1 receptor agonist

Weekly tirzepatide confers substantial weight loss in obesity without diabetes: SURMOUNT-1

Added to Collection on: 2022-06-04 21:02:12

Tags for this article:

Medical specialties
Clinical medicine
Organ systems
Peptide hormones
Diabetes
Neuropeptides
Tirzepatide
Semaglutide
Obesity
Glucagon-like peptide-1 receptor agonist
Bariatrics
Prediabetes
Robert H. Eckel

Click the tags to see associated articles and topics

View Article Details
Newer diabetes drugs can lead to weight loss. Wish it was that simple. | DC Injury Lawyers - JDSupra

Added to Collection on: 2022-06-20 18:28:53

Tags for this article:

Peptide hormones
Health
Medical specialties
Semaglutide
Liraglutide
Novo Nordisk
Diabetes
Obesity
Pharmaceutical industry
Blood sugar level
Anti-obesity medication
Glucagon-like peptide-1 receptor agonist
United States

Click the tags to see associated articles and topics

View Article Details
LLY NVO stocks in focus as Morgan Stanley projects over $50B obesity market (NYSE:LLY)

Added to Collection on: 2022-07-17 16:25:16

Tags for this article:

Peptide hormones
Medical specialties
Hormones
Life Sciences
LLY
Obesity
Tirzepatide
Glucagon-like peptide-1 receptor agonist
Semaglutide
Anti-obesity medication
Novo Nordisk
Eli Lilly
Chugai Pharmaceutical

Click the tags to see associated articles and topics

View Article Details
Carmot Therapeutics Closes $160 Million Series D - Silicon Valley Daily

Added to Collection on: 2022-07-29 20:49:54

Tags for this article:

Peptide hormones
Hormones
Organ systems
Branches of biology
Intestinal hormones
Diabetes
Anti-diabetic drugs
Incretin
Glucagon-like peptide-1 receptor agonist
Glucagon-like peptide-1
Receptor modulator
Gastric inhibitory polypeptide
Carmot Therapeutics Inc.

Click the tags to see associated articles and topics

View Article Details
TikTok trend wipes out Ozempic supply, leaving people with diabetes dizzy, scared

Added to Collection on: 2022-12-23 22:24:02

Tags for this article:

RTT
Health
Medicine
Organ systems
Diabetes
Pharmacy
Clinical pharmacology
Novo Nordisk
Anti-diabetic medication
Glucagon-like peptide-1 receptor agonist
Type 1 diabetes
Insulin
Shane Anthony
Novo Nordisk A/S
Francisco Prieto
u.s. food and drug administration

Click the tags to see associated articles and topics

View Article Details
Novo Nordisk diabetes pill wins FDA approval for first-line use - BioPharma Dive

Added to Collection on: 2023-01-13 22:52:17

Tags for this article:

Diabetes
RTT
Organ systems
Endocrine system
Endocrine diseases
Diabetes management
Novo Nordisk
Glucagon-like peptide-1 receptor agonist
Glucagon-like peptide-1
Semaglutide
Sitagliptin
Type 2 diabetes
Merck & Co.
Eli Lilly

Click the tags to see associated articles and topics

View Article Details
3 Stocks to Focus on as Demand for Obesity Drugs Booms - 24/7 Wall St.

Added to Collection on: 2023-09-30 21:00:44

Tags for this article:

Peptide hormones
Glucagon-like peptide-1 receptor agonist
Anti-obesity medication
Semaglutide
Retatrutide
Tirzepatide
Novo Nordisk
Obesity
Orforglipron
United States

Click the tags to see associated articles and topics

View Article Details
Wall Street just revealed a surprising new potential winner and loser of the Ozempic craze

Added to Collection on: 2023-10-03 20:38:51

Tags for this article:

Peptide hormones
Anti-diabetic drugs
Semaglutide
Glucagon-like peptide-1
Obesity
Diabetes medication
Diabetes
Tirzepatide
Glucagon-like peptide-1 receptor agonist
Anti-obesity medication

Click the tags to see associated articles and topics

View Article Details
Palatin Announces Positive Preclinical Data Showing Synergistic Weight Loss - BioSpace

Added to Collection on: 2023-10-18 18:26:01

Tags for this article:

G protein-coupled receptors
Peptide hormones
Aphrodisiacs
Peptides
Melanocortin 4 receptor
Melanocortin
Anti-diabetic drugs
Glucagon-like peptide-1 receptor agonist
Glucagon-like peptide-1
Bremelanotide
Agouti-related peptide
Obesity
GLP-1
Palatin Technologies Inc.

Click the tags to see associated articles and topics

View Article Details
Goldman Sachs predicts Ozempic and other weight-loss drugs to drive remarkable 16-fold ...

Added to Collection on: 2023-11-04 20:42:00

Tags for this article:

Peptide hormones
Semaglutide
Novo Nordisk
Anti-obesity medication
Goldman Sachs
Glucagon-like peptide-1
Obesity
Eli Lilly and Company
Weight loss
Pharmaceutical industry in China
Pharmaceutical industry
Glucagon-like peptide-1 receptor agonist

Click the tags to see associated articles and topics

View Article Details